Recent news on Ursodiol

Axcan Pharma Continues Solid Growth in Fiscal 2007, With Record ...  -  May 10, 2007
SYS-CON Media,Axcan and its partner, NicOx SA, have been co-developing NCX-1000, a patented, nitric oxide-donating derivative of ursodiol, for the treatment of portal

Callisto Reports on 2006 and First-Quarter 2007 Clinical and ...  -  Apr 16, 2007
PR Newswire (press release),The protocol was amended in 2006 to enable combination of ursodiol. Patients are presently being treated at 180 mg Atiprimod dose plus Ursodiol.

Strong Start for Axcan Pharma's Fiscal 2007, With Record Revenue ...  -  Feb 8, 2007
Genetic Engineering News (press release),Axcan and its partner, NicOx SA, are developing NCX-1000, a patented, nitric oxide-donating derivative of ursodiol, for the treatment of portal hypertension

Canada: Methods Of Medical Treatment – A New Twist On An Old ...  -  Nov 28, 2006
Mondaq News Alerts (subcription),The ’590 patent is directed to ursodeoxycholic acid, or Ursodiol, which is used in the treatment of primary biliary cirrhosis. ...

Axcan Pharma Closes Fiscal 2006 with Record Annual Revenue of ...  -  Nov 30, 2006
Market Wire (press release)Axcan and its partner, NicOx SA, are developing NCX-1000, a patented, nitric oxide-donating derivative of ursodiol, for the treatment of portal hypertension, a ...

Unscratchable itch  -  Nov 22, 2006
Daytona Beach News-Journal,Finally, at Week 25, Shannon was prescribed Ursodiol, generic for Actigall. ... The good thing was the success stories of women using Ursodiol were high. ...

Foro de Shell Security - Seguridad informática  Oct 27, 2006
Flow cytometry sho ursodiol s that the CD34-cell population, which contains the stem ce vvs ls and the early committed progenitors, is substantially redu ... -Shell Security, Liver drug aimed at diabetes  Aug 29, 2006
The medicines, ursodiol, for the liver and gallbladder, and Buphenyl, which fights a sometimes fatal genetic disorder, lowered blood sugar to normal levels in ... -Newsday

Canada: Methods Of Medical Treatment – A New Twist On An Old ...  -  Nov 28, 2006
Mondaq News Alerts (subcription),The ’590 patent is directed to ursodeoxycholic acid, or Ursodiol, which is used in the treatment of primary biliary cirrhosis. The patent is listed on the

Unscratchable itch  -  Nov 22, 2006
Daytona Beach News-Journal,Finally, at Week 25, Shannon was prescribed Ursodiol, generic for Actigall. We were hesitant to take an unknown medicine during pregnancy, but we gave it a

Axcan Pharma Closes Fiscal 2006 with Record Annual Revenue of ...  -  Nov 30, 2006
Genetic Engineering News (press release),Axcan and its partner, NicOx SA, are developing NCX-1000, a patented, nitric oxide-donating derivative of ursodiol, for the treatment of portal hypertension

Tigers, bears and rhino traded in London  -  Nov 17, 2006
This is Local London,Bear bile contains the acid Ursodiol, which breaks down gallstones. However, according to the Met's wildlife crime unit, there are at least 54 herbal

Liver drug aimed at diabetes  29 Aug 2006
The medicines, ursodiol, for the liver and gallbladder, and Buphenyl, which fights a sometimes fatal genetic disorder, lowered blood sugar to normal levels in ... -Newsday

Axcan and NicOx sign a co-development and license agreement  Aug 7, 2006
...announced today the signing of a co-development and license agreement with NicOx SA ("NicOx") for NCX 1000, a nitric oxide-donating ursodiol derivative, for ... -Biotechnology Investment Today

Axcan Announces Strong Third Quarter 2006 Revenue of $76.7 Million ...  Aug 10, 2006
Axcan and its partner, NicOx SA, are developing NCX-1000, a patented, nitric oxide-donating derivative of ursodiol, for the treatment of portal hypertension, a ... -Market Wire



Axcan announces record revenue of $72.8 million for the second ...  May 4, 2006
NCX-1000 Axcan and its partner, NicOx SA, are developing NCX-1000, a patented, nitric oxide donating derivative of ursodiol, for the treatment of portal ... - Canada NewsWire

Axcan announces record revenue of $72.8 million for the second ...  May 4, 2006
Axcan and its partner, NicOx SA, are developing NCX-1000, a patented, nitric oxide donating derivative of ursodiol, for the treatment of portal hypertension, a ... - Yahoo! News





Axcan announces record revenue of $70.6 million for the first ...  Feb 9, 2006
Axcan and its partner, NicOx SA, are developing NCX-1000, a patented, nitric oxide donating derivative of ursodiol, for the treatment of portal hypertension, a ... - Yahoo! News

Axcan announces record revenue of $70.6 million for the first ...  09 Feb 2006
NCX-1000 Axcan and its partner, NicOx SA, are developing NCX-1000, a patented, nitric oxide donating derivative of ursodiol, for the treatment of portal ... - PR Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional